Purchase Order 75N93022P00922
Award Date 7/29/22
Potential Completion Date 8/29/22
Potential Value $80K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $14,090 contract is for custom protein production services to support biomedical research and public health initiatives. The award is not associated with a larger contract vehicle and does not have a set-aside designation....
- This is a firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $12,714.08, is for customized protein expression and plasmid preparation services. This award is not a set-aside contract. The contract supports research activities at NIAID, which is the lead NIH institute...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $6,965.30, is for the production of customized protein production in a baculovirus expression system. The award does not have a set-aside designation. Genscript USA Inc. has received numerous prime and subcontract...
- This is a $186,509 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company. The contract is for testing expression and purification services for virus glycoproteins in vitro. This requirement was sole-sourced to Genscript under the authority of FAR 13.106-1, as NIAID determined Genscript to be the only responsible source that...
- This federal contract award, valued at $13,587.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of a customized protein service in a bacterial expression system, involving the production of 3 mg of protein for 6 different proteins. This purchase order contract has a firm fixed price pricing type and does not utilize any set-aside designations. Genscript...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $20,827.75 purchase order to Genscript USA Inc. to provide customized protein production using a baculovirus expression system. Performance will take place in Piscataway, New Jersey over a period of approximately three months concluding in mid-December 2023. The firm fixed price contract calls for Genscript to deliver the requested proteins without further...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $18,820.52, is for the production of customized DNA and monoclonal antibodies. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that specializes in advanced...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide custom-produced biotinylated and non-biotinylated proteins. The $45,035.54 contract supports the mission of the Vaccine Research Center, which had previously used Genscript's proteins in downstream experiments. The contract has no set-aside designation. Genscript, based in Piscataway,...
- The federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to GenScript USA Incorporated, a biotechnology company based in Piscataway, New Jersey. The $35,155.40 firm fixed-price purchase order did not have a set-aside designation. The contract supports GenScript's provision of specialized biological materials and services, including gene synthesis, protein production, and antibody...